Cognitive dysfunctions in recreational and dependent cocaine users: Role of attention-deficit hyperactivity disorder, craving and early age at onset

British Journal of Psychiatry

Volumn 203, Issue 1, 2013, Pages 35-43

  Vonmoos, Matthias ^a   Hulka, Lea M ^a   Preller, Katrin H ^a   Jenni, Daniela ^a   Baumgartner, Markus R ^a   Stohler, Rudolf ^a   Bolla, Karen I ^b   Quednow, Boris B ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; COCAINE DEPENDENCE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DECLARATIVE MEMORY; DEPRESSION; EXECUTIVE FUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; ONSET AGE; RISK ASSESSMENT; TASK PERFORMANCE; WITHDRAWAL SYNDROME; WORKING MEMORY;

ADULT; AGE OF ONSET; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COCAINE-RELATED DISORDERS; COGNITION; COGNITION DISORDERS; DRUG USERS; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 84879663431     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.112.118091     Document Type: Article

References (67)

1. European Monitoring Centre for Drugs and Drug Addiction. Annual Report 2012: The State of the Drugs Problem in Europe. Publications Office of the European Union, 2012.
2. Nutt D, King LA, Saulsbury W, Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet 2007; 369: 1047-53. (Pubitemid 46436128)
3. Wagner FA, Anthony JC. From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology 2002; 26: 479-88. (Pubitemid 34260997)
4. Degenhardt L, Hall, W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012; 379: 55-70.
5. Beveridge TJ, Gill KE, Hanlon CA, Porrino LJ. Review. Parallel studies of cocaine-related neural and cognitive impairment in humans and monkeys. Philos Trans R Soc Lond B Biol Sci 2008; 363: 3257-66.
6. Garavan H, Hester R. The role of cognitive control in cocaine dependence. Neuropsychol Rev 2007; 17: 337-45. (Pubitemid 47498177)
7. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 2009; 56: 3-8.
8. Volkow ND, Fowler JS, Wang GJ, Swanson JM. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry 2004; 9: 557-69. (Pubitemid 38850435)
9. Bolla K, Ernst M, Kiehl K, Mouratidis M, Eldreth D, Contoreggi C, et al. Prefrontal cortical dysfunction in abstinent cocaine abusers. J Neuropsychiatry Clin Neurosci 2004; 16: 456-64. (Pubitemid 39648347)
10. Ersche KD, Barnes A, Jones PS, Morein-Zamir S, Robbins TW, Bullmore ET. Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence. Brain 2011; 134: 2013-24.
11. Franklin TR, Acton PD, Maldjian JA, Gray JD, Croft JR, Dackis CA, et al. Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol Psychiatry 2002; 51: 134-42. (Pubitemid 34127903)
12. Lucantonio F, Stalnaker TA, Shaham Y, Niv Y, Schoenbaum G. The impact of orbitofrontal dysfunction on cocaine addiction. Nat Neurosci 2012; 15: 358-66.
13. Matochik JA, London ED, Eldreth DA, Cadet JL, Bolla KI. Frontal cortical tissue composition in abstinent cocaine abusers: a magnetic resonance imaging study. Neuroimage 2003; 19: 1095-102. (Pubitemid 36918247)
14. Sim ME, Lyoo IK, Streeter CC, Covell J, Sarid-Segal O, Ciraulo DA, et al. Cerebellar gray matter volume correlates with duration of cocaine use in cocaine-dependent subjects. Neuropsychopharmacology 2007; 32: 2229-37. (Pubitemid 47417695)
15. Cabeza R, Nyberg L. Imaging cognition II: An empirical review of 275 PET and fMRI studies. J Cogn Neurosci 2000; 12: 1-47. (Pubitemid 30142782)
16. Goldstein RZ, Leskovjan AC, Hoff AL, Hitzemann R, Bashan F, Khalsa SS, et al. Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex. Neuropsychologia 2004; 42: 1447-58. (Pubitemid 38891392)
17. Jovanovski D, Erb S, Zakzanis KK. Neurocognitive deficits in cocaine users: a quantitative review of the evidence. J Clin Exp Neuropsychol 2005; 27: 189-204. (Pubitemid 40389048)
18. Woicik PA, Moeller SJ, Alia-Klein N, Maloney T, Lukasik TM, Yeliosof O, et al. The neuropsychology of cocaine addiction: recent cocaine use masks impairment. Neuropsychopharmacology 2009; 34: 1112-22.
19. Bolla KI, Rothman R, Cadet JL. Dose-related neurobehavioral effects of chronic cocaine use. J Neuropsychiatry Clin Neurosci 1999; 11: 361-9. (Pubitemid 29408482)
20. Cunha PJ, Nicastri S, Gomes LP, Moino RM, Peluso MA. Neuropsychological impairments in crack cocaine-dependent inpatients: preliminary findings. Rev Bras Psiquiatr 2004; 26: 103-6. (Pubitemid 38937471)
21. Pace-Schott EF, Morgan PT, Malison RT, Hart CL, Edgar C, Walker M, et al. Cocaine users differ from normals on cognitive tasks which show poorer performance during drug abstinence. Am J Drug Alcohol Abuse 2008; 34: 109-21.
22. Smith MJ, Thirthalli J, Abdallah AB, Murray RM, Cottler LB. Prevalence of psychotic symptoms in substance users: a comparison across substances. Compr Psychiatry 2009; 50: 245-50.
23. Colzato LS, van den Wildenberg WP, Hommel B. Reduced attentional scope in cocaine polydrug users. PLoS One 2009; 4: e6043.
24. Colzato LS, Hommel B. Recreational use of cocaine eliminates inhibition of return. Neuropsychology 2009; 23: 125-9.
25. Colzato LS, Huizinga M, Hommel B. Recreational cocaine polydrug use impairs cognitive flexibility but not working memory. Psychopharmacology (Berl) 2009; 207: 225-34.
26. Colzato LS, van den Wildenberg WP, Hommel B. Impaired inhibitory control in recreational cocaine users. PLoS One 2007; 2: e1143.
27. Rahman Q, Clarke CD. Sex differences in neurocognitive functioning among abstinent recreational cocaine users. Psychopharmacology (Berl) 2005; 181: 374-80. (Pubitemid 41492208)
28. Reske M, Eidt CA, Delis DC, Paulus MP. Nondependent stimulant users of cocaine and prescription amphetamines show verbal learning and memory deficits. Biol Psychiatry 2010; 68: 762-9.
29. Soar K, Mason C, Potton A, Dawkins L. Neuropsychological effects associated with recreational cocaine use. Psychopharmacology (Berl) 2012; 222: 633-43.
30. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA, 1994.
31. Hulka LM, Wagner M, Preller KH, Jenni D, Quednow BB. Blue-yellow colour vision impairment and cognitive deficits in occasional and dependent stimulant users. Int J Neuropsychopharmacol 2013; 16: 535-47.
32. Preller KH, Ingold N, Hulka LM, Vonmoos M, Jenni D, Baumgartner MR, et al. increased sensorimotor gating in recreational and dependent cocaine users is modulated by craving and attention-deficit/hyperactivity disorder symptoms. Biol Psychiatry 2013; 73 : 225-34.
33. Perez de Los Cobos J, Sinol N, Puerta C, Cantillano V, Lopez Zurita C, Trujols J. Features and prevalence of patients with probable adult attention deficit hyperactivity disorder who request treatment for cocaine use disorders. Psychiatry Res 2011; 185: 205-10.
34. Swendsen JD, Merikangas KR. The comorbidity of depression and substance use disorders. Clin Psychol Rev 2000; 20: 173-89. (Pubitemid 30100431)
35. Wittchen HU, Wunderlich U, Gruschwitz S, Zaudig M. SKID-I. Strukturiertes Klinisches Interview für DSM-IV Achse I: Psychische Störungen. [SCID-I. Structured Clinical Interview for DSM-IV Axis I Disorders]. Hogrefe, 1997.
36. Quednow BB, Kuhn KU, Hoenig K, Maier W, Wagner M. Prepulse inhibition and habituation of acoustic startle response in male MDMA ('ecstasy') users, cannabis users, and healthy controls. Neuropsychopharmacology 2004; 29: 982-90. (Pubitemid 38526798)
37. Lehrl S. Mehrfachwahl-Wortschatz-Intelligenztest (MWT-B) (4th edn). Hogrefe, 1999.
38. Sussner BD, Smelson DA, Rodrigues S, Kline A, Losonczy M, Ziedonis D. The validity and reliability of a brief measure of cocaine craving. Drug Alcohol Depend 2006; 83: 233-7.
39. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991; 86: 1119-27.
40. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-71.
41. Rosler M, Retz W, Retz-Junginger P, Thome J, Supprian T, Nissen T, et al. Tools for the diagnosis of attention-deficit/hyperactivity disorder in adults. Self-rating behaviour questionnaire and diagnostic checklist [In German]. Nervenarzt 2004; 75: 888-95. (Pubitemid 39312514)
42. Strauss E, Sherman EMS, Spreen O. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. Third Edition. Oxford University Press, 2006.
43. Helmstaedter C, Lendt M, Lux S. Verbaler Lern- und Merkfä higkeitstest [Verbal Learning and Memory Test]. Beltz, 2001.
44. Wechsler DA. Wechsler Memory Scale (3rd edn) Manual. Psychological Corporation, 1997.
45. Kemps E, Tiggemann M. A Cognitive experimental approach to understanding and reducing food cravings. Curr Dir Psychol Sci 2010; 19: 86-90.
46. Sayette MA, Schooler JW, Reichle ED. Out for a smoke: the impact of cigarette craving on zoning out during reading. Psychol Sci 2010; 21: 26-30.
47. Cooper GA, Kronstrand R, Kintz P. Society of Hair Testing guidelines for drug testing in hair. Forensic Sci Int 2012; 218: 20-4.
48. Hoelzle C, Scheufler F, Uhl M, Sachs H, Thieme D. Application of discriminant analysis to differentiate between incorporation of cocaine and its congeners into hair and contamination. Forensic Sci Int 2008; 176: 13-8.
49. Substance Abuse and Mental Health Services Administration. Mandatory guidelines for federal workplace drug testing programs. Federal Register 2008; 73: 71858-907.
50. Hautzinger M, Bailer M, Worall H, Keller F. Beck-Depressions-Inventar (BDI). Testhandbuch. Zweite, überarbeitete Auflage [Beck Depression Inventory: Test Manual. Second Edition]. Huber, 1994.
51. Yochim B, Baldo J, Nelson A, Delis DC. D-KEFS Trail Making Test performance in patients with lateral prefrontal cortex lesions. J Int Neuropsychol Soc 2007; 13: 704-9. (Pubitemid 350017945)
52. Manes F, Sahakian B, Clark L, Rogers R, Antoun N, Aitken M, et al. Decision-making processes following damage to the prefrontal cortex. Brain 2002; 125: 624-39. (Pubitemid 34194416)
53. Owen AM, Evans AC, Petrides M. Evidence for a two-stage model of spatial working memory processing within the lateral frontal cortex: a positron emission tomography study. Cereb Cortex 1996; 6: 31-8.
54. Owen AM, Sahakian BJ, Semple J, Polkey CE, Robbins TW. Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia 1995; 33: 1-24.
55. Janowsky JS, Shimamura AP, Kritchevsky M, Squire LR. Cognitive impairment following frontal lobe damage and its relevance to human amnesia. Behav Neurosci 1989; 103: 548-60. (Pubitemid 19161168)
56. Alexander MP, Stuss DT, Fansabedian N. California Verbal Learning Test: performance by patients with focal frontal and non-frontal lesions. Brain 2003; 126: 1493-503. (Pubitemid 36644392)
57. Benedict RH, Zivadinov R, Carone DA, Weinstock-Guttman B, Gaines J, Maggiore C, et al. Regional lobar atrophy predicts memory impairment in multiple sclerosis. AJNR Am J Neuroradiol 2005; 26: 1824-31. (Pubitemid 43853687)
58. Ersche KD, Jones PS, Williams GB, Robbins TW, Bullmore ET. Cocaine dependence: a fast-track for brain ageing? Mol Psychiatry 2012: 18: 134-5.
59. Ersche KD, Jones PS, Williams GB, Turton AJ, Robbins TW, Bullmore ET. Abnormal brain structure implicated in stimulant drug addiction. Science 2012; 335: 601-4.
60. Volkow ND, Fowler JS, Wolf AP, Hitzemann R, Dewey S, Bendriem B, et al. Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry 1991; 148: 621-6.
61. Volkow ND, Hitzemann R, Wang GJ, Fowler JS, Wolf AP, Dewey SL, et al. Long-term frontal brain metabolic changes in cocaine abusers. Synapse 1992; 11: 184-90.
62. Gotlib IH, Joormann J. Cognition and depression: current status and future directions. Annu Rev Clin Psychol 2010; 6: 285-312.
63. Valera EM, Brown A, Seidman LJ. Neuropsychology of ADHD and other disorders of childhood. In The Neuropsychology of Mental Illness (eds EM Valera, A Brown, LJ Seidman): 285-99. Cambridge University Press, 2010.
64. Shen LH, Liao MH, Tseng YC. Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders. J Biomed Biotechnol 2012; 2012: 1-14.
65. Liston C, Malter Cohen M, Teslovich T, Levenson D, Casey BJ. Atypical prefrontal connectivity in attention-deficit/hyperactivity disorder: pathway to disease or pathological end point? Biol Psychiatry 2011; 69: 1168-77.
66. Moeller KE, Lee KC, Kissack JC. Urine drug screening: practical guide for clinicians. Mayo Clin Proc 2008; 83: 66-76.
67. Curran HV. Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research. Neuropsychobiology 2000; 42: 34-41. (Pubitemid 30436314)